Regulatory T-cells from Pancreatic Lymphnodes of Patients with Type-1 Diabetes Express Increased Levels of MicroRNA MiR-125a-5p That Limits CCR2 Expression

Overview

Journal Sci Rep

Specialty Science

Date 2017 Aug 2

PMID 28761107

Citations 30

Authors

Guido Sebastiani

Giuliana Ventriglia

Angela Stabilini

Carlo Socci

Cristina Morsiani

Andrea Laurenzi

Laura Nigi

Caterina Formichi

Bechara Mfarrej

Alessandra Petrelli

Georgia Fousteri

Todd M Brusko

Francesco Dotta

Manuela Battaglia

Affiliations

Soon will be listed here.

Abstract

Autoimmune type 1 diabetes (T1D) is thought to be caused by a defective immune regulation with regulatory T (Treg) cells playing a fundamental role in this process. Tolerance mechanisms depend on tunable responses that are sensitive to minor perturbations in the expression of molecules that can be carried out by multiple epigenetic mechanisms, including regulation by microRNAs. In this study, microRNA expression profile was investigated in Treg cells isolated from peripheral blood (PB) and from pancreatic draining lymph nodes (PLN) of T1D patients and non-diabetic subjects. Among 72 microRNAs analyzed, miR-125a-5p resulted specifically hyper-expressed in Treg cells purified from PLN of T1D patients. TNFR2 and CCR2 were identified as miR-125a-5p target genes. Elevated miR-125a-5p was detected in Treg cells isolated from PLN but not from PB of donors with T1D and was associated with reduced CCR2 expression. A specific beta-cell expression of the CCR2-ligand (CCL2) was observed in the pancreata of cadaveric donors, suggesting that beta-cells are prone to attract CCR2 Treg cells. These novel data propose a mechanism, occurring in PLNs of T1D patients, involving increased expression of miR-125a-5p on Treg cells which results into reduced expression of CCR2, thus limiting their migration and eventual function in the pancreas.

Citing Articles

Oral Insulin Delay of Stage 3 Type 1 Diabetes Revisited in HLA DR4-DQ8 Participants in the TrialNet Oral Insulin Prevention Trial (TN07).

Zhao L, Papadopoulos G, Skyler J, Parikh H, Kwok W, Bondinas G Diabetes Care. 2024; 47(9):1608-1616.

PMID: 38949847 PMC: 11362107. DOI: 10.2337/dc24-0573.

A set of circulating microRNAs belonging to the 14q32 chromosome locus identifies two subgroups of individuals with recent-onset type 1 diabetes.

Sebastiani G, Grieco G, Bruttini M, Auddino S, Mori A, Toniolli M Cell Rep Med. 2024; 5(6):101591.

PMID: 38838677 PMC: 11228666. DOI: 10.1016/j.xcrm.2024.101591.

Increased intracellular miR-142 in adults with Type 1 diabetes.

Huang L, Januszewski A, Takahashi Y, ONeal D, Ma J, Jenkins A J Diabetes Complications. 2023; 37(10):108597.

PMID: 37659140 PMC: 10592019. DOI: 10.1016/j.jdiacomp.2023.108597.

Pancreatic draining lymph nodes (PLNs) serve as a pathogenic hub contributing to the development of type 1 diabetes.

Sun F, Yang C, Wang F, Rong S, Luo J, Lu W Cell Biosci. 2023; 13(1):156.

PMID: 37641145 PMC: 10464122. DOI: 10.1186/s13578-023-01110-7.

Insulin-like Growth Factor-1 Synergizes with IL-2 to Induce Homeostatic Proliferation of Regulatory T Cells.

Shapiro M, Peters L, Brown M, Cabello-Kindelan C, Posgai A, Bayer A J Immunol. 2023; 211(7):1108-1122.

PMID: 37594278 PMC: 10511790. DOI: 10.4049/jimmunol.2200651.

References

Zhang N, Schroppel B, Lal G, Jakubzick C, Mao X, Chen D . Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. Immunity. 2009; 30(3):458-69. PMC: 2737741. DOI: 10.1016/j.immuni.2008.12.022. View

Pan W, Zhu S, Dai D, Liu Z, Li D, Li B . MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis. Nat Commun. 2015; 6:7096. DOI: 10.1038/ncomms8096. View

Buckner J . Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010; 10(12):849-59. PMC: 3046807. DOI: 10.1038/nri2889. View

Allantaz F, Cheng D, Bergauer T, Ravindran P, Rossier M, Ebeling M . Expression profiling of human immune cell subsets identifies miRNA-mRNA regulatory relationships correlated with cell type specific expression. PLoS One. 2012; 7(1):e29979. PMC: 3262799. DOI: 10.1371/journal.pone.0029979. View

Hiraoka N, Onozato K, Kosuge T, Hirohashi S . Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions. Clin Cancer Res. 2006; 12(18):5423-34. DOI: 10.1158/1078-0432.CCR-06-0369. View

Piemonti L, Leone B, Nano R, Saccani A, Monti P, Maffi P . Human pancreatic islets produce and secrete MCP-1/CCL2: relevance in human islet transplantation. Diabetes. 2002; 51(1):55-65. DOI: 10.2337/diabetes.51.1.55. View

Lim H, Broxmeyer H, Kim C . Regulation of trafficking receptor expression in human forkhead box P3+ regulatory T cells. J Immunol. 2006; 177(2):840-51. DOI: 10.4049/jimmunol.177.2.840. View

Ferraro A, Socci C, Stabilini A, Valle A, Monti P, Piemonti L . Expansion of Th17 cells and functional defects in T regulatory cells are key features of the pancreatic lymph nodes in patients with type 1 diabetes. Diabetes. 2011; 60(11):2903-13. PMC: 3198077. DOI: 10.2337/db11-0090. View

Tang F, Hajkova P, Barton S, Lao K, Surani M . MicroRNA expression profiling of single whole embryonic stem cells. Nucleic Acids Res. 2006; 34(2):e9. PMC: 1351374. DOI: 10.1093/nar/gnj009. View

10.

Li D, Kong C, Tsun A, Chen C, Song H, Shi G . MiR-125a-5p Decreases the Sensitivity of Treg cells Toward IL-6-Mediated Conversion by Inhibiting IL-6R and STAT3 Expression. Sci Rep. 2015; 5:14615. PMC: 4589732. DOI: 10.1038/srep14615. View

11.

Campbell D, Koch M . Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat Rev Immunol. 2011; 11(2):119-30. PMC: 3289970. DOI: 10.1038/nri2916. View

12.

Tang F, Hajkova P, Barton S, OCarroll D, Lee C, Lao K . 220-plex microRNA expression profile of a single cell. Nat Protoc. 2007; 1(3):1154-9. DOI: 10.1038/nprot.2006.161. View

13.

Ventriglia G, Nigi L, Sebastiani G, Dotta F . MicroRNAs: Novel Players in the Dialogue between Pancreatic Islets and Immune System in Autoimmune Diabetes. Biomed Res Int. 2015; 2015:749734. PMC: 4538424. DOI: 10.1155/2015/749734. View

14.

Tonkin D, Haskins K . Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-beta-dependent manner. Eur J Immunol. 2009; 39(5):1313-22. PMC: 2939012. DOI: 10.1002/eji.200838916. View

15.

Bartel D . MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116(2):281-97. DOI: 10.1016/s0092-8674(04)00045-5. View

16.

Zhao X, Tang Y, Qu B, Cui H, Wang S, Wang L . MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus. Arthritis Rheum. 2010; 62(11):3425-35. DOI: 10.1002/art.27632. View

17.

Brusko T, Wasserfall C, McGrail K, Schatz R, Viener H, Schatz D . No alterations in the frequency of FOXP3+ regulatory T-cells in type 1 diabetes. Diabetes. 2007; 56(3):604-12. DOI: 10.2337/db06-1248. View

18.

Willcox A, Richardson S, Bone A, Foulis A, Morgan N . Analysis of islet inflammation in human type 1 diabetes. Clin Exp Immunol. 2009; 155(2):173-81. PMC: 2675247. DOI: 10.1111/j.1365-2249.2008.03860.x. View

19.

Djuranovic S, Nahvi A, Green R . miRNA-mediated gene silencing by translational repression followed by mRNA deadenylation and decay. Science. 2012; 336(6078):237-40. PMC: 3971879. DOI: 10.1126/science.1215691. View

20.

Bartel D . MicroRNAs: target recognition and regulatory functions. Cell. 2009; 136(2):215-33. PMC: 3794896. DOI: 10.1016/j.cell.2009.01.002. View